Levodropropizine in the management of cough associated with cancer or nonmalignant chronic diseaseA systematic review

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 25, Issue 3, 2011, Pages 209-218

  Schildmann, Eva Katharina ^a   Rémi, Constanze ^b   Bausewein, Claudia ^c  

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic cough; Cough; Levodropropizine; Palliative care

Indexed keywords

DIHYDROCODEINE; LEVDROPROPIZINE; MOGUISTEINE; PLACEBO;

ANXIETY DISORDER; ARTICLE; ASTHMA; BRONCHITIS; CHRONIC BRONCHITIS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COUGHING; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEART FAILURE; HUMAN; INSOMNIA; INTERSTITIAL LUNG DISEASE; NEOPLASM; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL;

ANTITUSSIVE AGENTS; CHRONIC DISEASE; COUGH; HEART FAILURE; HUMANS; LUNG DISEASES; NEOPLASMS; PROPYLENE GLYCOLS;

EID: 82155198843     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2011.583979     Document Type: Article

References (32)

1. Muers MF, Round CE. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax. 1993;48:339-343. (Pubitemid 23126299)
2. Hopwood P, Stephens RJ. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 1995;71:633-636.
3. [3 Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer. 2000;8:175-179. (Pubitemid 30183032)
4. [4 Donnelly S,Walsh D. The symptoms of advanced cancer. Semin Oncol. 1995;22(2 Suppl 3):67-72.
5. [5 Edmonds P, Karlsen S, Khan S, Addington-Hall J. A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med. 2001;15:287-295. (Pubitemid 32640547)
6. Myers J. Physiology and pathophysiology of cough. In: Ahmedzai SH, Muers MF, eds. Supportive Care in Respiratory Disease. Oxford, UK: Oxford University Press; 2005:341-364.
7. Homsi J, Walsh D, Nelson KA. Important drugs for cough in advanced cancer. Support Care Cancer. 2001;9:565-574. (Pubitemid 33069378)
8. Thomas T, Wade R, Booth S. Other respiratory symptoms (cough, hiccup, and secretions). In: Bruera E, Higginson I, Ripamonti C, Gunten CV, eds. Textbook of Palliative Medicine. London: Hodder Arnold; 2006:663-672.
9. Leach RM. Palliative medicine and non-malignant, end-stage respiratory disease. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine (895-916). Oxford, UK: Oxford University Press; 2005.
10. Chung KF. Currently available cough suppressants for chronic cough [conference paper. Lung. 2008;186(Suppl):S82-S87. (Pubitemid 351327284)
11. Eddy NB, Friebel H, Hahn KJ, Halbach H. Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanism, methodology and evaluation. BullWorld Health Organ. 1969;40:425-454.
12. Ahmedzai SH. Cough in cancer patients. Pulm Pharmacol Ther. 2004;17:415-423. (Pubitemid 39582720)
13. Daffonchio L, Clavenna G, Fedele G, Omini C. Levodropropizine [review. Drug Today. 1995;31:299-305.
14. Shams H, Daffonchio L, Scheid P. Effects of levodropropizine on vagal afferent C-fibre in the cat. Br J Pharmacol. 1996;117:853-858. (Pubitemid 26075963)
15. Chan K-S, Sham MMK, Tse DMW, Thorsen AB. Palliative medicine in malignant respiratory diseases. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford, UK: Oxford University Press; 2005:587-618.
16. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines [review. Chest. 2006;129:238-249.
17. CRD. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. CRD Report 4. 2nd ed. Centre for Reviews and Dissemination; 2001. Accessed April 1, 2008; Available at:
18. [18 Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51:1235-1241. (Pubitemid 29009523)
19. Gysels M, Higginson IJ. Systematic reviews. In: Addington- Hall JM, Bruera E, Higginson IJ, Payne S, eds. Research Methods in Palliative Care. Oxford, UK: Oxford University Press; 2007:115-136.
20. Luporini G, Barni S, Marchi E, Daffonchio L. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J. 1998;12:97-101. (Pubitemid 28325660)
21. Allegra L, Bossi R. Clinical trials with the new antitussive levodropropizine in adult bronchitic patients. Arzneimittelforschung. 1988;38:1163-1166.
22. Fasciolo G, Nicolini A, Vacca N, Viglierchio P. Efficacy and safety of moguisteine in comparison with levodropropizine in patients with cough associated with chronic obstructive pulmonary disease, lung cancer, or pulmonary fibrosis. Curr Ther Res. 1994;55:251-261.
23. Aversa C, Cazzola M, Clini V, Dal Negro R, Maiorano V, Tana F, et al. Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases. Drugs Exp Clin Res. 1993;19:273-279. (Pubitemid 24068373)
24. Barnabe R, Berni F, Clini V, Pirrelli M, Pisani Ceretti A, Robuschi M, et al. The efficacy and safety of moguisteine in comparison with codeine phosphate in patients with chronic cough. Monaldi Arch Chest Dis. 1995;50:93-97.
25. Eccles R. The powerful placebo in cough studies? [see comment. Pulm Pharmacol Ther. 2002;15:303-308. (Pubitemid 34754125)
26. Irwin RS, Curley FJ. The treatment of cough. A comprehensive review. Chest. 1991;99:1477-1484.
27. Molassiotis A, Bailey C, Caress A, Brunton L, Smith J. Interventions for cough in cancer [review. Cochrane Database Syst Rev. 2010;(9): CD Art. No.: CD007881. DOI: 10.1002/ 14651858.CD007881.pub2.
28. Bossi R, Braga PC, Centanni S, Legnani D, Moavero NE, Allegra L. Antitussive activity and respiratory system effects of levodropropizine in man. Arzneimittelforschung. 1988;38: 1159-1162.
29. Cook AM, Finlay IG, Edwards AG, Hood K, Higginson IJ, Goodwin DM, et al. Efficiency of searching the grey literature in palliative care. J Pain Symptom Manage. 2001;22:797-801. (Pubitemid 32776591)
30. Catena E, Daffonchio L. Efficacy and tolerability of levodropropizine in adult patients with non-productive cough. Comparison with dextromethorphan. Pulm Pharmacol Ther. 1997;10(2):89-96. (Pubitemid 29094850)
31. Pontiroli AE, Daffonchio L. Efficacy and tolerability of levodropropizine and clobutinol in elderly patients with nonproductive cough. Clinical Drug Investigation. 1997;14(3):175-182. (Pubitemid 27437701)
32. Aliprandi P, Castelli C, Bernorio S, Dell'Abate E, Carrara M. Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents. Drugs Exp Clin Res. 2004;30(4):133-141. (Pubitemid 39487681)